Guidelines
- The diagnostic workup of myocarditis: which approach for whom and when - Presentation
- Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases - Publication
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC - Publication
- Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC) - Publication
- Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC Council of Cardio-Oncology—part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias - Publication
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) - Publication
- Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases - Publication
- Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy - Publication
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases - Publication
General overview
- Myocarditis
- aetiology and histopathological diagnosis - ESC Cardiomed textbook chapter
- clinical presentation - ESC Cardiomed textbook chapter
- imaging techniques - ESC Cardiomed textbook chapter
- MINOCA and COVID-19 - Presentation
- Myocarditis: diagnosis and management - Session
- Checkpoint inhibitor associated myocarditis - Presentation
- Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-induced myocarditis and myositis - Presentation
- Necrotizing fulminant eosinophilic myocarditis managed with mechanical support and high-dose of glucocorticoids: when a rare diagnosis is only the beginning of the fight for life! Presentation
- Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination - Presentation
- Myocarditis Award Lecture - Session
- Specific forms of myocarditis - Session
- HoT track - myocarditis: from diagnosis to treatment - Session
- Specific forms of myocarditis - Session
- Catch up: diagnosis of myocarditis - Session
- Inflammation in heart failure: from myocardial infarction, HFrEF, HFpEF to myocarditis - Presentation
- Causes of sudden cardiac death in the young - Presentation
- Post-COVID consequences for the heart: insights from single cell analysis - Presentation
- Cardiovascular consequences post-COVID: bench to bedside – discussion - Presentation
- Influenza, COVID-19, and the risk of cardiac events - Presentation
- Accuracy of ICD-10 codes for patients with acute myocarditis: a retrospective study at a large tertiary centre in London, UK - Presentation
Essentials
- COVID-19 myocarditis and myocardial injury: active participant or innocent bystander? - Presentation
- Myocarditis: the role of cardiac imaging and endomyocardial biopsy - Presentation
- Symptomatology, prognosis, and clinical findings of COVID 19 induced myocarditis: a systematic review - Presentation
- Acute fulminant myocarditis with challenging differential diagnosis - Presentation
- Targeting cardiac inflammation: from myocarditis to heart failure - Presentation
- Immunotherapy for cardiovascular disease – discussion - Presentation
Assessment
- Biventricular arrhythmogenic cardiomyopathy diagnosed 29 years after the first presentation with myocarditis - Presentation
- A temporally associated COVID-19 mRNA vaccination related myocarditis presenting with heart failure with reduced ejection fraction after the first dose - Presentation
- EACVI preparatory course to certification in CMR - Exam
- More facets of acute myocarditis - Presentation
- Acute cardiogenic shock secondary to right ventricular myocarditis following recovery from COVID-19 infection - Presentation
- Acute pericarditis followed by transient myocarditis: A case of immune checkpoint inhibitor related cardiotoxicity in a 63 year old female - Presentation
- A case of eosinophilic myocarditis mimicking acute coronary syndrome - Presentation
- Q fever myocarditis - Presentation
- Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? - Chat Moderator - Presentation
Evidence
- Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology - Podcast
- What we (don't) know about myocardial injury after COVID-19 - Podcast
- Essential update on multi-modality imaging during and after symptomatic COVID infection - Presentation
- Myocardial inflammation / myocarditis after COVID-19 mRNA booster vaccination - Presentation
- COVID-19-related and post-vaccine myocarditis
- Impact of myocardial injury on mortality and adverse events in hospitalized patients with influenza: a prospective cohort study
Management
- Diagnose and treat VT in myocarditis - Presentation
- Exercise after acute COVID myocarditis - Presentation
- CMR in the evaluation of non-ischaemic cardiomyopathies - Presentation
- The diagnostic workup of myocarditis: which approach for whom and when - Presentation
- The diagnostic workup of infiltrative and inflammatory cardiac diseases – discussion - Presentation
- Case 1: diagnosis and treatment of acute and unstable myocarditis - Presentation
- Stimulation of cardiomyocyte proliferation - Presentation
- COVID-19 myocarditis and myocardial injury: active participant or innocent bystander? - Presentation
- Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? – discussion - Presentation
- Vaccination for COVID-19 and cardiovascular risk prevention - Presentation
- Cd4+ t cell phenotypes, autoantibodies and transcriptional signatures overlap between myocarditis, ischemic and nonischaemic heart failure, suggesting shared inflammatory pathogenic mechanisms - Presentation
- COVID-19 vaccine-induced myocarditis vs. Immune checkpoint inhibitor-induced myocarditis - Same but different? - Presentation
- COVID-19 vaccination in the pediatric age and risk for myocarditis - Presentation
- The PROPELLA-concept in fulminant myocarditis - Presentation
- Myocarditis: treatment advances and future directions - Presentation
Interaction with the patient
- When and how to allow sport activities for patients recovering from myocarditis - Presentation
- When and how to allow sport activities: a general cardiologist's perspective – discussion - Presentation
Interaction with the specialist
- Acute cardiogenic shock secondary to right ventricular myocarditis following recovery from COVID-19 infection - Presentation
- Q fever myocarditis - Presentation
- Diagnose and treat VT in myocarditis - Presentation
- RNA vaccines: an opportunity for cardiovascular diseases? - Presentation
- Meet the Experts: cardiovascular catastrophes in critical care – advanced therapies in acute myocarditis and electrical storm – discussion - Presentation
Test yourself
ESC Education Committee Contributors to this Topic of the Month
Want to stay up-to-date?
Discover our communities' activities:
Our mission: To reduce the burden of cardiovascular disease.